private:mimetas
|
2939905
|
May 30th, 2019 12:00AM
|
MIMETAS
|
3.0K
|
98.00
|
Open
|
Biotechnology
|
May 29th, 2019 08:18PM
|
May 29th, 2019 08:18PM
|
High-throughput Human Disease and Tissue Models
MIMETAS BV develops organ-on-a-chip tissue models for evaluating drugs, chemicals and food components. Its unique microfluidic technology, designated OrganoPlates®, enables testing of compounds in high-throughput on miniaturized organ models. These models show better predictivity as compared to laboratory animals and conventional cell culture models. The OrganoPlate® platform supports 3D cell culture under continuous perfusion and membrane-free co-culture, including epithelial and endothelial boundary tissues. MIMETAS offers OrganoPlates®, develops and validates customised disease, toxicology and transport models and will ultimately make her technology available for personalised therapy selection.
|
Open
|
organ-on-a-chip, microfluidics, 3D cell culture, cell-based assays, toxicology, tissue models, disease models, microphysiological systems, MPS, organoids, blood-brain barrier, liver, brain models, liver models, kidney models
|
Open
|
JH Oortweg 19
|
Leiden
|
|
NL
|
2333 CH
|
|
Mimetas
|
|
Health Care Equipment & Services
|
private:mimetas
|
2939905
|
Feb 17th, 2018 12:00AM
|
MIMETAS - The Organ on a Chip Company
|
1.2K
|
52.00
|
Open
|
Biotechnology
|
Feb 17th, 2018 02:25PM
|
Feb 17th, 2018 02:25PM
|
High-throughput Human Disease and Tissue Models MIMETAS BV develops organ-on-a-chip tissue models for evaluating drugs, chemicals and food components. Its unique microfluidic technology, designated OrganoPlates®, enables testing of compounds in high-throughput on miniaturized organ models. These models show better predictivity as compared to laboratory animals and conventional cell culture models. The OrganoPlate® platform supports 3D cell culture under continuous perfusion and membrane-free co-culture, including epithelial and endothelial boundary tissues. MIMETAS offers OrganoPlates®, develops and validates customised disease, toxicology and transport models and will ultimately make her technology available for personalised therapy selection.
|
|
|
|
|
|
|
|
|
|
Mimetas
|
|
Health Care Equipment & Services
|
private:mimetas
|
2939905
|
Feb 16th, 2018 12:00AM
|
MIMETAS - The Organ on a Chip Company
|
1.2K
|
52.00
|
Open
|
Biotechnology
|
Feb 16th, 2017 08:15AM
|
Feb 16th, 2017 08:15AM
|
High-throughput Human Disease and Tissue Models
MIMETAS BV develops organ-on-a-chip tissue models for evaluating drugs, chemicals and food components. Its unique microfluidic technology, designated OrganoPlates®, enables testing of compounds in high-throughput on miniaturized organ models. These models show better predictivity as compared to laboratory animals and conventional cell culture models. The OrganoPlate® platform supports 3D cell culture under continuous perfusion and membrane-free co-culture, including epithelial and endothelial boundary tissues. MIMETAS offers OrganoPlates®, develops and validates customised disease, toxicology and transport models and will ultimately make her technology available for personalised therapy selection.
|
|
|
|
|
|
|
|
|
|
Mimetas
|
|
Health Care Equipment & Services
|
private:mimetas
|
2939905
|
Feb 15th, 2018 12:00AM
|
MIMETAS - The Organ on a Chip Company
|
1.2K
|
52.00
|
Open
|
Biotechnology
|
Feb 15th, 2017 10:07AM
|
Feb 15th, 2017 10:07AM
|
High-throughput Human Disease and Tissue Models
MIMETAS BV develops organ-on-a-chip tissue models for evaluating drugs, chemicals and food components. Its unique microfluidic technology, designated OrganoPlates®, enables testing of compounds in high-throughput on miniaturized organ models. These models show better predictivity as compared to laboratory animals and conventional cell culture models. The OrganoPlate® platform supports 3D cell culture under continuous perfusion and membrane-free co-culture, including epithelial and endothelial boundary tissues. MIMETAS offers OrganoPlates®, develops and validates customised disease, toxicology and transport models and will ultimately make her technology available for personalised therapy selection.
|
|
|
|
|
|
|
|
|
|
Mimetas
|
|
Health Care Equipment & Services
|
private:mimetas
|
2939905
|
Feb 14th, 2018 12:00AM
|
MIMETAS - The Organ on a Chip Company
|
1.2K
|
45.00
|
Open
|
Biotechnology
|
Feb 14th, 2017 01:50PM
|
Feb 14th, 2017 01:50PM
|
High-throughput Human Disease and Tissue Models
MIMETAS BV develops organ-on-a-chip tissue models for evaluating drugs, chemicals and food components. Its unique microfluidic technology, designated OrganoPlates®, enables testing of compounds in high-throughput on miniaturized organ models. These models show better predictivity as compared to laboratory animals and conventional cell culture models. The OrganoPlate® platform supports 3D cell culture under continuous perfusion and membrane-free co-culture, including epithelial and endothelial boundary tissues. MIMETAS offers OrganoPlates®, develops and validates customised disease, toxicology and transport models and will ultimately make her technology available for personalised therapy selection.
|
|
|
|
|
|
|
|
|
|
Mimetas
|
|
Health Care Equipment & Services
|
private:mimetas
|
2939905
|
Feb 13th, 2018 12:00AM
|
MIMETAS - The Organ on a Chip Company
|
1.2K
|
45.00
|
Open
|
Biotechnology
|
Feb 13th, 2017 04:11PM
|
Feb 13th, 2017 04:11PM
|
High-throughput Human Disease and Tissue Models
MIMETAS BV develops organ-on-a-chip tissue models for evaluating drugs, chemicals and food components. Its unique microfluidic technology, designated OrganoPlates®, enables testing of compounds in high-throughput on miniaturized organ models. These models show better predictivity as compared to laboratory animals and conventional cell culture models. The OrganoPlate® platform supports 3D cell culture under continuous perfusion and membrane-free co-culture, including epithelial and endothelial boundary tissues. MIMETAS offers OrganoPlates®, develops and validates customised disease, toxicology and transport models and will ultimately make her technology available for personalised therapy selection.
|
|
|
|
|
|
|
|
|
|
Mimetas
|
|
Health Care Equipment & Services
|
private:mimetas
|
2939905
|
Feb 12th, 2018 12:00AM
|
MIMETAS - The Organ on a Chip Company
|
1.2K
|
45.00
|
Open
|
Biotechnology
|
Feb 12th, 2017 04:15AM
|
Feb 12th, 2017 04:15AM
|
High-throughput Human Disease and Tissue Models
MIMETAS BV develops organ-on-a-chip tissue models for evaluating drugs, chemicals and food components. Its unique microfluidic technology, designated OrganoPlates®, enables testing of compounds in high-throughput on miniaturized organ models. These models show better predictivity as compared to laboratory animals and conventional cell culture models. The OrganoPlate® platform supports 3D cell culture under continuous perfusion and membrane-free co-culture, including epithelial and endothelial boundary tissues. MIMETAS offers OrganoPlates®, develops and validates customised disease, toxicology and transport models and will ultimately make her technology available for personalised therapy selection.
|
|
|
|
|
|
|
|
|
|
Mimetas
|
|
Health Care Equipment & Services
|
private:mimetas
|
2939905
|
Feb 11th, 2018 12:00AM
|
MIMETAS - The Organ on a Chip Company
|
1.2K
|
45.00
|
Open
|
Biotechnology
|
Feb 11th, 2017 05:35AM
|
Feb 11th, 2017 05:35AM
|
High-throughput Human Disease and Tissue Models
MIMETAS BV develops organ-on-a-chip tissue models for evaluating drugs, chemicals and food components. Its unique microfluidic technology, designated OrganoPlates®, enables testing of compounds in high-throughput on miniaturized organ models. These models show better predictivity as compared to laboratory animals and conventional cell culture models. The OrganoPlate® platform supports 3D cell culture under continuous perfusion and membrane-free co-culture, including epithelial and endothelial boundary tissues. MIMETAS offers OrganoPlates®, develops and validates customised disease, toxicology and transport models and will ultimately make her technology available for personalised therapy selection.
|
|
|
|
|
|
|
|
|
|
Mimetas
|
|
Health Care Equipment & Services
|
private:mimetas
|
2939905
|
Feb 10th, 2018 12:00AM
|
MIMETAS - The Organ on a Chip Company
|
1.2K
|
45.00
|
Open
|
Biotechnology
|
Feb 10th, 2017 06:43AM
|
Feb 10th, 2017 06:43AM
|
High-throughput Human Disease and Tissue Models
MIMETAS BV develops organ-on-a-chip tissue models for evaluating drugs, chemicals and food components. Its unique microfluidic technology, designated OrganoPlates®, enables testing of compounds in high-throughput on miniaturized organ models. These models show better predictivity as compared to laboratory animals and conventional cell culture models. The OrganoPlate® platform supports 3D cell culture under continuous perfusion and membrane-free co-culture, including epithelial and endothelial boundary tissues. MIMETAS offers OrganoPlates®, develops and validates customised disease, toxicology and transport models and will ultimately make her technology available for personalised therapy selection.
|
|
|
|
|
|
|
|
|
|
Mimetas
|
|
Health Care Equipment & Services
|
private:mimetas
|
2939905
|
Feb 9th, 2018 12:00AM
|
MIMETAS - The Organ on a Chip Company
|
1.2K
|
45.00
|
Open
|
Biotechnology
|
Feb 9th, 2017 08:57AM
|
Feb 9th, 2017 08:57AM
|
High-throughput Human Disease and Tissue Models
MIMETAS BV develops organ-on-a-chip tissue models for evaluating drugs, chemicals and food components. Its unique microfluidic technology, designated OrganoPlates®, enables testing of compounds in high-throughput on miniaturized organ models. These models show better predictivity as compared to laboratory animals and conventional cell culture models. The OrganoPlate® platform supports 3D cell culture under continuous perfusion and membrane-free co-culture, including epithelial and endothelial boundary tissues. MIMETAS offers OrganoPlates®, develops and validates customised disease, toxicology and transport models and will ultimately make her technology available for personalised therapy selection.
|
|
|
|
|
|
|
|
|
|
Mimetas
|
|
Health Care Equipment & Services
|